Gabapentinoids - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	71.72%
INSURED CONSUMERS
% of insured consumers	1.76%
Median age	64 years
Max/min ratio of the median age (by district)	1.13
Percentage of women	60.36%
Ratio Preferential scheme/General scheme	2.31
Coefficient of variation (2022)	21.89
Max/min ratio of % of insured consumers (by district)	2.40
CONSUMPTION
Annual consumption (DDD)	27,521,533
Consumption of DDD (per 100,000 insured persons)	239,983.45
% DDD issued outside the insurance (approximate)	7.55%
Average annual consumption per insured consumer (DDD)	136.35
% of insured consumers with > 3 times the average consumption	7.00%
Coefficient of variation (% of insured consumers) 2012-2014	19.82
Coefficient of variation (% of insured consumers) 2020-2022	17.76
Trend 2012-2022	9.35%
Trend 2012-2019	11.61%
Trend 2019-2022	4.27%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	16,973,029€
Average annual expenditure per insured person	1.48 €
Average patient share per insured consumer	19.12%
Max/min ratio of expenditure per insured person (by disctrict)	1.97
% “Low-cost” medication	99.98%
Trend 2012-2022	-3.15%
Trend 2019-2022	0.38%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.